CLDX
Celldex Therapeutics Inc.

9,702
Mkt Cap
$1.96B
Volume
1.07M
52W High
$29.83
52W Low
$14.40
PE Ratio
-8.71
CLDX Fundamentals
Price
$29.45
Prev Close
$29.60
Open
$29.50
50D MA
$26.10
Beta
1.04
Avg. Volume
869,324.32
EPS (Annual)
-$2.45
P/B
3.27
Rev/Employee
$37,741.93
Loading...
Loading...
News
all
press releases
Celldex Therapeutics (NASDAQ:CLDX) Reaches New 12-Month High - Here's Why
Celldex Therapeutics (NASDAQ:CLDX) Sets New 1-Year High - Time to Buy...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Envestnet Asset Management Inc. Buys Shares of 42,287 Celldex Therapeutics, Inc. $CLDX
Envestnet Asset Management Inc. bought a new stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities...
MarketBeat·15d ago
News Placeholder
Celldex Therapeutics, Inc. $CLDX Shares Bought by TSP Capital Management Group LLC
TSP Capital Management Group LLC boosted its stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 10.6% in the 2nd quarter, according to the company in its most recent Form...
MarketBeat·18d ago
News Placeholder
Celldex Therapeutics (NASDAQ:CLDX) Insider Richard Wright Sells 49,298 Shares
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) insider Richard Wright sold 49,298 shares of the firm's stock in a transaction on Thursday, November 13th. The shares were sold at an...
MarketBeat·20d ago
News Placeholder
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eleven analysts that are currently covering the firm...
MarketBeat·20d ago
News Placeholder
Celldex Therapeutics (NASDAQ:CLDX) Trading Up 7.4% - What's Next?
Celldex Therapeutics (NASDAQ:CLDX) Trading Up 7.4% - Still a Buy...
MarketBeat·21d ago
News Placeholder
HC Wainwright Issues Pessimistic Estimate for CLDX Earnings
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) - Analysts at HC Wainwright reduced their FY2025 earnings per share estimates for Celldex Therapeutics in a report released on Tuesday, November...
MarketBeat·24d ago
News Placeholder
FY2025 Earnings Estimate for CLDX Issued By Leerink Partnrs
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) - Research analysts at Leerink Partnrs lowered their FY2025 earnings per share (EPS) estimates for Celldex Therapeutics in a research note...
MarketBeat·24d ago
News Placeholder
FY2025 Earnings Forecast for CLDX Issued By Lifesci Capital
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) - Analysts at Lifesci Capital dropped their FY2025 earnings estimates for Celldex Therapeutics in a report released on Monday, November 10th...
MarketBeat·24d ago
News Placeholder
What is Lifesci Capital's Forecast for CLDX FY2025 Earnings?
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) - Equities research analysts at Lifesci Capital reduced their FY2025 earnings estimates for Celldex Therapeutics in a research note issued to...
MarketBeat·24d ago

Latest CLDX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.